On August 11, Hims & Hers Health Inc. fell 5.51% in after-hours trading, trading at $29.96/share, with turnover of $27.14 million.

The decline was triggered by the company's Q2 earnings report, which revealed a per-share loss of $(0.37), dramatically missing the analyst consensus estimate of $(0.03) by over 1,100%. This represents a significant deterioration from earnings of $0.17 per share in the year-ago quarter. However, quarterly revenue of $753.2 million beat the consensus estimate of $699.9 million.

Despite the revenue beat and management reaffirming confidence in accelerating domestic business growth in the second half, as well as its long-term target of at least $6.5 billion in revenue and $1.3 billion in adjusted EBITDA by 2030, the magnitude of the earnings miss weighed heavily on investor sentiment. The prior quarter had already shown a net loss of $92.1 million with a net margin of -15.15%, and the widening losses signal continued margin pressure as the telehealth platform invests in growth.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)